EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND  OF BENEFICIAL INTEREST

EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND OF BENEFICIAL INTEREST

Action · US2772531008 (XNYS)
Aperçu
Analyse alimentée par l’IA
Analyse fondamentale
Découvrez ce que disent vraiment les chiffres — avant le marché
Analyser maintenant
Sentiment des actualités
Les actualités d’aujourd’hui sont-elles un signal d’achat ou un avertissement ?
Analyser maintenant
Acheter / Conserver / Vendre
Faut-il acheter, conserver ou vendre ? Obtenez l’avis de l’IA dès maintenant.
Analyser maintenant
Évaluation des risques
Détectez les risques cachés avant qu’ils n’impactent votre portefeuille.
Analyser maintenant
Juste valeur
Cette action est-elle bon marché, correctement valorisée ou surévaluée ?
Analyser maintenant
Dernières analyses d’IA sur EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND OF BENEFICIAL INTEREST
Pas de cours
28.04.2026 20:00
Cours actuels de EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND OF BENEFICIAL INTEREST
BourseTickerDeviseDernier échangeCoursVariation journalière
OTC: UTC
UTC
ETBI
USD
28.04.2026 20:00
0,001 USD
0,00 USD
Profil de l'entreprise pour EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND OF BENEFICIAL INTEREST Action
EastGate Biotech Corp. is a pharmaceutical company. The Company produces and distributes nutraceuticals that are based on natural therapies and absorbed naturally by the body. It utilizes state-of-the-art nanotechnologies to deliver healthy alternatives to conventional pharmaceuticals that all too often create dangerous side effects and unexpected consequences for those trying to attain and maintain healthy lives. The Company’s products include E-Drops NANO, Essential D, GluCora, VCleanzz, Cleanezze and Warts X. The Company develops products in which the components are incorporated into vehicles containing nano-sized delivery vectors, including oil droplets (nanoemulsions), polymeric particles (nanoparticles) and the combination of polymers and lipids with surfactants (hybrid nanoparticles, nanocapsules, mixed micelles). It has its offices in New York, London SF, Cockfosters BP, Los Angeles, Chicago and Las Vegas.

Données de l'entreprise

Nom EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND OF BENEFICIAL INTEREST
Société Eastgate Biotech Corp.
Site web www.EastGateBiotech.com
Marché d'origine XNYS NYSE
ISIN US2772531008
Type de titre Action
Secteur Healthcare
Industrie Medical - Pharmaceuticals
PDG Rosella C. Perri
Pays États-Unis d'Amérique
Devise USD
Employés 0,0 T
Adresse 65 Harbour Square Suite 2203Toronto, M5J 2L4Canada, Toronto
Date d'introduction en bourse 2014-03-05

Symboles boursiers

Nom Symbole
Over The Counter ETBI
Autres actions
Les investisseurs qui détiennent EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND OF BENEFICIAL INTEREST ont également les actions suivantes dans leur portefeuille :
Horizon Space Acquisition II Corp. - Ordinary share
Horizon Space Acquisition II Corp. - Ordinary share Action
N.Y.LIFE GLOBAL FDG 18/28
N.Y.LIFE GLOBAL FDG 18/28 Obligation